ACCC Submits Comments for Senate Finance Hearing on Prescription Drug Prices


March 29, 2022

In response to a Senate Finance Committee Hearing entitled "Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare", ACCC submitted a statement for the record highlighting concerns with proposed drug pricing legislation.
Read Letter


«« Previous
ACCC Asks Congress to Increase Funding for Lung Cancer Research Program
Next »»
ACCC Encourages Congress to Fund Cancer Moonshot Initiatives

Categories

ACCC on Twitter